Loading...
FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice
Breast cancers commonly become resistant to EGFR–tyrosine kinase inhibitors (EGFR-TKIs); however, the mechanisms of this resistance remain largely unknown. We hypothesized that resistance may originate, at least in part, from molecular alterations that activate signaling downstream of EGFR. Using a...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3428077/ https://ncbi.nlm.nih.gov/pubmed/22886303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI60498 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|